Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
KAI Pharmaceuticals
KAI Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Parsabiv
Etelcalcetide
2017-02-07
2030-2034
Secondary hyperparathyroidism
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Etelcalcetide
hyperparathyroidism
,
secondary hyperparathyroidism
,
neoplasm metastasis
,
chronic kidney disease-mineral and bone disorder
,
chronic renal insufficiency
,
kidney diseases
,
bone diseases
Benzocaine
large b-cell lymphoma diffuse
,
multiple myeloma
,
b-cell chronic lymphocytic leukemia
,
follicular lymphoma
,
recurrence
,
lymphoma
,
glioma
,
hodgkin disease
,
mantle-cell lymphoma
,
b-cell lymphoma
,
triple negative breast neoplasms
,
renal cell carcinoma
,
carcinoma
,
hypertension
,
infections
,
chronic hepatitis b
,
communicable diseases
,
lung neoplasms
,
parkinson disease
,
parkinsonian disorders
,
movement disorders
,
dyskinesias
,
myositis
,
giant cell arteritis
,
polymyalgia rheumatica
,
chronic renal insufficiency
,
uveitis
,
pituitary acth hypersecretion
,
acth-secreting pituitary adenoma
,
graft vs host disease
,
type 1 diabetes mellitus
,
hypoglycemia
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
brain neoplasms
,
astrocytoma
,
oligodendroglioma
,
pancreatic neoplasms
,
insulinoma
,
neuroendocrine tumors
,
islet cell carcinoma
,
gastrinoma
,
glucagonoma
,
somatostatinoma
,
mucositis
,
psoriasis
,
breast neoplasms
,
myelodysplastic syndromes
,
thrombocytopenia
,
preleukemia
,
syndrome
,
macular edema
,
retinal vein occlusion
,
vision disorders
,
low vision
,
macular degeneration
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
juvenile arthritis
,
arthritis
,
kidney diseases
,
myocardial infarction
,
infarction
,
inferior wall myocardial infarction
,
organ transplantation
,
wet macular degeneration
,
neoplasm metastasis
,
graft rejection
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
,
postoperative pain
,
toothache
,
choroidal neovascularization
,
pathologic neovascularization
,
chronic kidney failure
,
renal insufficiency
,
liver transplantation
,
kidney transplantation
,
hepatitis c
,
hepatitis
,
hepatitis a
,
ankylosing spondylitis
,
spondylarthritis
,
spondylitis
,
liver cirrhosis
,
fibrosis
,
atrial fibrillation
DELCASERTIB
myocardial infarction
,
infarction
,
cardiovascular diseases
,
pathologic processes
Velcalcetide
chronic kidney failure
,
neoplasm metastasis
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
chronic renal insufficiency
,
kidney diseases
,
left ventricular hypertrophy
,
cardiomegaly
,
hypertrophy
Arm1
prostatic hyperplasia
,
hyperplasia
,
psychological sexual dysfunctions
,
anxiety disorders
,
generalized anxiety disorder
,
hypertension
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
hiv infections
,
erectile dysfunction
,
wounds and injuries
,
spinal cord injuries
,
spinal injuries
,
type 2 diabetes mellitus
,
diabetes mellitus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use